• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.19% Nasdaq Down 0.35%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    21.61 Down 0.66(2.98%) 12:55PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:22.27
    Open:22.30
    Bid:21.63 x 100
    Ask:21.65 x 300
    1y Target Est:33.11
    Beta:3.44
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:21.23 - 22.47
    52wk Range:10.76 - 33.33
    Volume:956,712
    Avg Vol (3m):2,986,900
    Market Cap:1.94B
    P/E (ttm):N/A
    EPS (ttm):-1.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLDX

    Comparison

    Symbol% ChgMkt Cap
    CLDXDown 2.98%1.94B
    DNDNDown 13.61%N/A
    LLYUp 0.35%76.18B
    RHHBYDown 1.10%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):731.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.32
    Quarterly EPS Est (Dec-14) :-0.35
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback